Patents by Inventor Samuel Rogers

Samuel Rogers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11931492
    Abstract: A system and method for balancing flows of renal replacement fluid is disclosed. The method uses pressure controls and pressure sensing devices to more precisely meter and balance the flow of fresh dialysate and spent dialysate. The balancing system may use one or two balancing devices, such as a balance tube, a tortuous path, or a balance chamber.
    Type: Grant
    Filed: June 30, 2021
    Date of Patent: March 19, 2024
    Assignees: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE SA
    Inventors: Michael E. Hogard, Donald D. Busby, Robert W. Childers, Yuanpang Samuel Ding, Katherine M. Holian, Mark E. Jablonski, Thomas D. Kelly, Shincy J. Maliekkal, Rodolfo G. Roger, Donald A. Smith, Atif M. Yardimci, Ying-Cheng Lo
  • Publication number: 20230210418
    Abstract: Implementations relate generally to devices for measuring an analyte in a host. Implementations may provide reduced sizes for wearable devices including a transcutaneous analyte sensor for analyte measurement.
    Type: Application
    Filed: December 30, 2022
    Publication date: July 6, 2023
    Inventors: John Charles Barry, Elshad Abdullayev, Eunsook Chae Barber, Patrick J. Castagna, John Durham, Craig Thomas Gadd, Carl E. Hoffmeier, Nicholas Kalfas, Mark Kempkey, Young Woo Lee, Nicolas Medjo, Carl Pettersen, Will Reyna, Morgan Alexander Robinson, Samuel Rogers, Jeffrey J. Smith, Terry Thom, Shanger Wang, James Woodward
  • Publication number: 20230210410
    Abstract: Implementations relate generally to devices for measuring an analyte in a host. Implementations may provide reduced sizes for wearable devices including a transcutaneous analyte sensor for analyte measurement.
    Type: Application
    Filed: December 30, 2022
    Publication date: July 6, 2023
    Inventors: John Charles Barry, Elshad Abdullayev, Eunsook Chae Barber, Patrick J. Castagna, John Durham, Craig Thomas Gadd, Cari E. Hoffmeier, Nicholas Kalfas, Mark Kempkey, Young Woo Lee, Nicolas Medjo, Carl Pettersen, Will Reyna, Morgan Alexander Robinson, Samuel Rogers, Jeffrey J. Smith, Terry Thom, Shanger Wang, James Woodward
  • Publication number: 20230210409
    Abstract: Implementations relate generally to devices for measuring an analyte in a host. Implementations may provide reduced sizes for wearable devices including a transcutaneous analyte sensor for analyte measurement.
    Type: Application
    Filed: December 30, 2022
    Publication date: July 6, 2023
    Inventors: John Charles Barry, Elshad Abdullayev, Eunsook Chae Barber, Patrick J. Castagna, John Durham, Craig Thomas Gadd, Carl E. Hoffmeier, Nicholas Kalfas, Mark Kempkey, Young Woo Lee, Nicolas Medjo, Carl Pettersen, Will Reyna, Morgan Alexander Robinson, Samuel Rogers, Jeffrey J. Smith, Terry Thom, Shanger Wang, James Woodward
  • Patent number: 10892397
    Abstract: Disclosed are systems and methods for a self-monitoring conducting system that can respond to temperature, strain, and/or radiation changes via the use of optical fibers. The self-monitoring conducting system comprises a conducting component integrated with one or more optical fibers. The temperature, strain, and/or radiation changes can be sensed or detected via optical interrogation of the one or more optical fibers.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: January 12, 2021
    Assignee: NORTH CAROLINA STATE UNIVERSITY
    Inventors: Justin Schwartz, Federico Scurti, Samuel Rogers, Wan Kan Chan
  • Publication number: 20200206215
    Abstract: New methods of treating schizophrenia and schizoaffective disorder by administration of pharmaceutical compositions comprising an antipsychotic compound and a VMAT2 inhibitor to a subject in need thereof are provided.
    Type: Application
    Filed: March 13, 2020
    Publication date: July 2, 2020
    Inventors: Samuel Roger Jesse Hoare, Dimitri E. Grigoriadis, Neil J. Ashweek
  • Publication number: 20190381029
    Abstract: New methods of treating schizophrenia and schizoaffective disorder by administration of pharmaceutical compositions comprising an antipsychotic compound and a VMAT2 inhibitor to a subject in need thereof are provided.
    Type: Application
    Filed: January 16, 2019
    Publication date: December 19, 2019
    Inventors: Samuel Roger Jesse Hoare, Dimitri E. Grigoriadis, Neil J. Ashweek
  • Publication number: 20180085364
    Abstract: New methods of treating schizophrenia and schizoaffective disorder by administration of pharmaceutical compositions comprising an antipsychotic compound and a VMAT2 inhibitor to a subject in need thereof are provided.
    Type: Application
    Filed: September 11, 2017
    Publication date: March 29, 2018
    Inventor: Samuel Roger Jesse Hoare
  • Patent number: 9782398
    Abstract: New methods of treating schizophrenia and schizoaffective disorder by administration of pharmaceutical compositions comprising an antipsychotic compound and a VMAT2 inhibitor to a subject in need thereof are provided.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: October 10, 2017
    Assignee: Neurocrine Biosciences, Inc.
    Inventor: Samuel Roger Jesse Hoare
  • Publication number: 20170179364
    Abstract: Disclosed are systems and methods for a self-monitoring conducting system that can respond to temperature, strain, and/or radiation changes via the use of optical fibers. The self-monitoring conducting system comprises a conducting component integrated with one or more optical fibers. The temperature, strain, and/or radiation changes can be sensed or detected via optical interrogation of the one or more optical fibers.
    Type: Application
    Filed: December 16, 2016
    Publication date: June 22, 2017
    Inventors: Justin Schwartz, Federico Scurti, Samuel Rogers, Wan Kan Chan
  • Publication number: 20160339011
    Abstract: New methods of treating schizophrenia and schizoaffective disorder by administration of pharmaceutical compositions comprising an antipsychotic compound and a VMAT2 inhibitor to a subject in need thereof are provided.
    Type: Application
    Filed: February 6, 2015
    Publication date: November 24, 2016
    Applicant: NEUROCRINE BIOSCIENCES, INC.
    Inventor: Samuel Roger Jesse HOARE
  • Publication number: 20110168015
    Abstract: A piston for an automatic transmission includes a cylindrical portion formed of a steel material and an elastomer bonded thereto. The elastomer includes an ethylene-acrylic polymer, a filler, and a hexamethylene diamine curing agent. The elastomer is compression or injection molded to the metal cylindrical portion. During the molding step, the elastomer is cured and achieves a cross-link density, strength, and other physical properties sufficient for use in an automatic transmission. Thus, the piston is formed without a post curing step. The piston provides a lower wear rate and a higher life expectancy than pistons formed with a post curing step.
    Type: Application
    Filed: January 7, 2011
    Publication date: July 14, 2011
    Inventor: Samuel Roger Holliday, JR.